Table 5.
Administration characteristics for IGSC 20% per age group
| Age group (years) | ||||||
|---|---|---|---|---|---|---|
| Parameters* | 2 to < 6 (n = 5) | 6 to < 12 (n = 8) | 12 to < 18 (n = 12) | 18 to < 65 (n = 20) | 65 and older (n = 3) | All patients (n = 48) |
| Duration of infusions (h) | ||||||
| Infusions (n) | 253 | 408 | 550 | 1009 | 115 | 2335 |
| Median | 0·75 | 1·0 | 1·0 | 1·0 | 0·5 | 0·95 |
| Min; max | (0·4; 3·0) | (0·4; 2·5) | (0·3; 3·3) | (0·3; 4·1) | (0·4; 2·3) | (0·3; 4·1) |
| Number of sites per infusion | ||||||
| Infusions (n) | 253 | 408 | 550 | 1012 | 115 | 2338 |
| Median | 1·0 | 2·0 | 2·0 | 2·0 | 2·0 | 2·0 |
| Min; max | (1; 2) | (1; 2) | (1; 4) | (1; 5) | (1; 3) | (1; 5) |
| Maximum infusion rate (ml/h/site) | ||||||
| Infusions (n) | 253 | 408 | 550 | 1012 | 115 | 2338 |
| Median | 20·0 | 15·0 | 23·5 | 20·0 | 40·0 | 20·0 |
| Min; max | (2·5; 40·0) | (5·0; 40·0) | (5·0; 40·0) | (5·0; 60·0) | (10·0; 40·0) | (2·5; 60·0) |
| Infusion volume (ml/site) | ||||||
| Infusions (n) | 253 | 408 | 550 | 1012 | 115 | 2338 |
| Median | 14·0 | 11·2 | 17·5 | 18·8 | 16·5 | 16·6 |
| Min; max | (6·5; 26·0) | (9·5; 27·0) | (10·0; 42·5) | (10·4; 48·0) | (11·1; 20·0) | (6·5; 48·0) |
*Only infusions with complete infusion parameters have been considered for each analyses. IGSC = subcutaneous immunoglobulin.